Covid-19: NZ company secures $3.3m for homegrown vaccine – New Zealand Herald

A local company has secured $3.3m in private funding to steam ahead with a Covid-19 vaccine made with Kiwi technology.
The Covid-19 Vaccine Corporation (CVC), set up in May, has formed collaborations with the University of Auckland, Callaghan Innovation, and research institute Scion, its bid to independently develop a homegrown coronavirus agent.
The company aims to complete its first human trial of the new vaccine by the end of next year, which will cost around $8 million.
“We are not aim…

Click here to view the original article.